Do I need to take gilitinib all the time?

Gilitinib is a targeted therapy drug used to treat FLT3 mutation-positive acute myeloid leukemia (AML). When patients take giritinib, they usually need to continue taking it according to their doctor's recommendations, but the specific situation depends on the individual's condition, treatment response, and doctor's guidance.

1.Continuous treatment: In most cases, giritinib is used as a long-term treatment regimen. AMLis a type of leukemia that often requires long-term treatment to maintain disease control and stability. Continuous use of giritinib can help inhibit the growth and spread of leukemia cells, reducing the progression of the disease and the risk of recurrence.

2.Physician’s guidance: Patients should always follow the doctor’s advice and prescription when using giritinib. Doctors usually determine the duration and dosage of a treatment plan based on factors such as the patient's condition, treatment response, and adverse reactions. During the treatment process, patients need regular follow-up and monitoring so that the treatment plan can be adjusted in a timely manner.

3.Treatment response and monitoring: Patients should pay close attention to the treatment response and adverse reactions while using giritinib. Regular blood tests and other clinical evaluations can help doctors evaluate the effectiveness of treatments and detect possible side effects or complications. Depending on the response to treatment, the doctor may adjust the treatment plan, including dosage adjustment or combination with other drugs.

4.Relapse and discontinuation: Although gilitinib can effectively controlAML's disease, in some cases, patients may still experience recurrence of the disease. If a patient's condition worsens or signs of recurrence appear, doctors may reassess the treatment plan and consider adjusting treatment strategies, including using other drugs or performing hematopoietic stem cell transplantation.

To sum up, giritinib usually requires continuous use, but the specific treatment plan depends on the patient's condition, treatment response and doctor's advice. Patients should pay close attention to the doctor's instructions while using giritinib and conduct regular follow-up and monitoring to ensure the effectiveness and safety of the treatment.